Table 2.
ESA Dose Change | HbAA | Any Hb Trait | HbAS | HbAC |
---|---|---|---|---|
Percent change in ESA dosea (95% CI) | Reference | 13.2 (5.1 to 21.9) | 13.2 (4.3 to 22.9) | 12.9 (−3.1 to 31.6) |
P=0.001 | P=0.003 | P=0.12 | ||
Percent change in weight-adjusted ESA doseb (95% CI) | Reference | 14.9 (6.3 to 24.2) | 15.3 (5.8 to 25.7) | 13.1 (−3.8 to 32.9) |
P<0.001 | P=0.001 | P=0.14 |
Any Hb trait, any hemoglobinopathy trait (includes HbAS and HbAC).
Linear regression model adjusted for age, sex, vintage, intact parathyroid hormone, albumin, Kt/V, ferritin, transferrin saturation, access type, iron dose, missed treatments, and hospitalizations.
Linear regression model adjusted for sex, vintage, intact parathyroid hormone, albumin, ferritin, transferrin saturation, access type, iron dose, missed treatments, and hospitalizations; age and Kt/V are excluded from this model.